NCT06105619: A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 84 taking part
- Started
- 8 Oct 2018
- Primary completion
- 1 Apr 2023
- Arms
- PLB1001
- Results
- None posted
- 8 Oct 2018: Trial started
- 27 Oct 2023: Trial registered